US Patent 7105489 Methods and compositions for treating polycystic ovary syndrome

Patent 7105489 was granted and assigned to Amylin Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amylin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71054890

Patent Inventor Names

David R. Hathaway0

Date of Patent

September 12, 2006

Patent Application Number

103171260

Date Filed

December 11, 2002

Patent Primary Examiner

‌

Jeffrey Edwin Russel

Patent abstract

The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1) to subjects suffering therefrom.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7105489 Methods and compositions for treating polycystic ovary syndrome

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API